IP Verse

The Broad Institute Inc. patent opposition analysis

Latest patents of The Broad Institute Inc. opposed by its competitors

The following table provides an overview of the latest patents of The Broad Institute Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3294873Sep 18, 2024Targeting Bcl11A Enhancer Functional Regions For Fetal Hemoglobin Reinduction1
EP3237615Jul 26, 2023Crispr Having Or Associated With Destabilization Domains2
EP3252160Oct 28, 2020Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation5
EP3011031Sep 30, 2020Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy2
EP3502253May 27, 2020Novel Crispr Enzymes And Systems4
EP3310917Feb 12, 2020Novel Crispr Enzymes And Systems4
EP3470519Feb 12, 2020Novel Crispr Enzymes And Systems4
EP3011032Oct 16, 2019Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells2
EP3066201Mar 7, 2018Crispr-Related Methods And Compositions With Governing Grnas2

Top competitors of The Broad Institute Inc.